Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.

The introduction of angiogenesis, epidermal growth factor receptor inhibitors, and other new anti-cancer agents is changing the present and future of this disease and will certainly increase the number of lung cancer survivors.